Kazuki Kodo Selected Research

Kazuki Kodo Research Topics

Disease

5	Obesity 01/2019 - 03/2014
4	Congenital Heart Defects (Congenital Heart Defect) 01/2019 - 08/2010
3	Hypoxia (Hypoxemia) 04/2019 - 09/2014
3	Myocardial Infarction 08/2015 - 09/2014
2	Body Weight (Weight, Body) 01/2019 - 01/2018
2	Insulin Resistance 01/2019 - 01/2017
2	Ischemia 08/2015 - 09/2014
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2015 - 09/2014
1	Hyperbilirubinemia 03/2022
1	Hyperlipidemias (Hyperlipidemia) 03/2022
1	Alagille Syndrome (Alagille-Watson Syndrome) 03/2022
1	Xanthomatosis (Xanthoma) 03/2022
1	Cyanosis 03/2022
1	Dyslipidemias (Dyslipidemia) 03/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2021
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 02/2021
1	Pseudohypoaldosteronism 02/2021
1	Hydronephrosis 02/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Pulmonary Arterial Hypertension 04/2019
1	Neurodevelopmental Disorders 01/2019
1	Hyperglycemia 01/2019
1	Rett Syndrome (Rett's Disorder) 01/2019
1	Heterotaxy Syndrome 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Teratoma (Teratoid Tumor) 02/2016
1	Reperfusion Injury 10/2014
1	Tetralogy of Fallot (Fallot Tetralogy) 10/2010
1	Atrial Heart Septal Defects (Atrial Septal Defect) 10/2010
1	Down Syndrome (Down's Syndrome) 08/2010
1	Persistent Truncus Arteriosus 08/2009
1	Macrophage Activation Syndrome 12/2006
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2006
1	Hypophosphatemia 12/2006
1	Hyponatremia 12/2006

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2017
2	Erythropoietin FDA Link 01/2019 - 01/2017
2	CytokinesIBA 08/2015 - 12/2006
2	MicroRNAs (MicroRNA)IBA 03/2015 - 09/2014
2	Transcription Factors (Transcription Factor)IBA 09/2014 - 01/2012
1	Pravastatin (Pravachol)FDA LinkGeneric 03/2022
1	Lipoproteins (Lipoprotein)IBA 03/2022
1	Triglycerides (Triacylglycerol)IBA 03/2022
1	Bile Acids and Salts (Bile Acids)IBA 03/2022
1	BilirubinIBA 03/2022
1	CholesterolIBA 03/2022
1	Fenofibrate (CiL)FDA LinkGeneric 03/2022
1	Atorvastatin (Lipitor)FDA Link 03/2022
1	AldosteroneIBA 02/2021
1	ReninIBA 02/2021
1	SodiumIBA 02/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2021
1	PotassiumIBA 02/2021
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2021
1	ThapsigarginIBA 04/2019
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 04/2019
1	CalpainIBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	HematinicsIBA 01/2019
1	LipidsIBA 01/2019
1	Methyl-CpG-Binding Protein 2IBA 01/2019
1	DEPOIBA 01/2019
1	angiotensin I (1-7)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2014
1	Mitochondrial Permeability Transition PoreIBA 10/2014
1	Green Fluorescent ProteinsIBA 09/2014
1	miglitol (Glyset)FDA Link 03/2014
1	Uncoupling Protein 1IBA 03/2014
1	GATA Transcription FactorsIBA 10/2010
1	Prostaglandins FIBA 08/2010
1	S- (2- (N,N- diisopropylamino)ethyl)isothioureaIBA 08/2010
1	ThromboxanesIBA 08/2010
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 08/2010
1	Thromboxane A2 (A2, Thromboxane)IBA 08/2010
1	GATA6 Transcription FactorIBA 08/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2006

Therapy/Procedure

3	Therapeutics 03/2022 - 02/2016
2	Transplantation 10/2017 - 08/2015
2	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2015 - 09/2014
1	Blalock-Taussig Procedure 03/2022
1	Critical Care (Surgical Intensive Care) 01/2019
1	Lasers (Laser) 08/2015